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Abstract
Introduction: Laughter is a good medicine; it enhances cardiovascular health and the immune
system. What happens, however, if a person laughs too much or the laughter becomes out of
control? Laughter-induced syncope is rare and likely goes unrecognized by many health care
providers. It is thought to be another form of Valsalva-induced syncope.
Case presentation: We report the case of a 56-year-old, moderately obese (body mass index of
35) man with a past medical history of sleep apnea, hypertension and hyperlipidemia who suffered
from syncope secondary to intense laughter. The patient also had a history of syncope in the distant
past when he collapsed on the floor for several seconds. Treadmill stress testing after the incident
revealed no arrhythmia or ischemic disease, although he complained of dizziness after the test and
a sudden drop in blood pressure was noted.
Conclusion: Laughter-induced or gelastic syncope is extremely rare. It is thought to be a sub-type
of the situational syncopes.
Introduction
Syncope is a transient loss of consciousness and postural
tone secondary to inadequate cerebral perfusion that
spontaneously resolves without medical intervention. It is
a relatively common clinical problem accounting for 1%
to 1.5% of emergency department visits and around 6% of
hospital admissions annually [1]. However, syncope
remains a diagnostic challenge for clinicians, as the differ-
ential diagnosis is extensive (Table 1). Among the various
classifications, neurally mediated, cardiac and unex-
plained etiologies appear to be the most common diag-
noses. In a prospective study of 341 patients presenting
with syncope, a cardiac cause of syncope was established
in 23% of the patients, a neurally mediated cause in 58%
and the cause of syncope remained unexplained in 18%
[2].
Laughter-induced or gelastic (derived from the Greek
word for laughter, 'gelos') syncope is extremely rare. It is a
sub-type of the situational syncopes hypothesized to be
the result of a neurally mediated reflex triggered by
increased intrathoracic pressure. Intense laughter causes
repetitive forced expirations in a staccato pattern with a
Valsalva-type effect. The associated increase in intratho-
racic pressure reduces venous return resulting in decreased
cardiac output and a transient reduction in cerebral per-
fusion. It has also been proposed that strenuous laughter
might produce isometric muscle contraction resulting in
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acute vascular dilatation, thereby exacerbating the reduc-
tion in venous return [3].
Normally the body is able to compensate for these
changes through cerebral vascular autoregulation and
autonomic reflexes. In one of the most well-known reflex
arcs, reduced cardiac output leads to decreased stimula-
tion of carotid sinus and aortic arch baroreceptors, as well
as mechanoreceptors in the left ventricle wall [4]. The
resulting increase in sympathetic tone maintains blood
pressure for adequate cerebral perfusion. However, in
neurally mediated syncopes, there is acute and inappro-
priate hypotension and bradycardia exacerbating the
reduction in cerebral perfusion, resulting in a transient
loss of consciousness. It is hypothesized that increased
ventricular contraction in response to reduced venous
return stimulates the left ventricle mechanoreceptors to a
degree that is able to override the baroreceptor reflex and
cause an inappropriate increase in parasympathetic tone
[4]. Aside from laughter-induced syncope, this mecha-
nism is also thought to account for syncope secondary to
coughing, sneezing and other Valsalva-related activities.
To the best of the authors' knowledge, only five cases of
laugh syncope among adults have been reported in the lit-
erature [3,5-8] (Table 2). We present the case of a 56-year-
old man who suffered from syncope secondary to intense
laughter.
Case presentation
A 56-year-old, moderately obese (body mass index of 35)
man with a past medical history of sleep apnea, hyperten-
sion and hyperlipidemia presented to his primary care
physician for routine health maintenance. He mentioned
that he had recently been very busy with overtime work,
which had left him exhausted. He informed the physician
of an incident that occurred one evening as he entertained
his colleagues in a fine restaurant. While waiting for the
meals to be served, a guest had told a very amusing joke
and the patient began to laugh heartily, "Ha, ha, ha, ha...
" in decrescendo until he was out of breath. To everyone's
surprise, he then fell forward resting his head on the table
and remained unresponsive for a few seconds before
regaining consciousness. Prior to losing consciousness, he
described feeling short of breath and noted that his sur-
roundings were becoming dark. No seizure-like activity or
incontinence was witnessed. After the episode he denied
nausea, diaphoresis or otherwise feeling sick and pro-
ceeded to eat when his entrée was served. The remainder
of the evening was without incident.
He had a history of syncope in the distant past in which
he had collapsed on the floor for several seconds follow-
ing hours of overtime work. Treadmill stress testing after
the incident revealed no arrhythmia or ischemic disease,
although he complained of dizziness after the test and a
sudden drop in blood pressure was noted. At the time, he
had been in poor physical condition with a sedentary life-
style. He was encouraged to exercise and remained free of
symptoms until this episode.
Discussion and conclusion
Laugh syncope was diagnosed in the patient based on his
characteristic presentation. Situational syncopes such as
laugh syncope are usually diagnosed using history from
the patient [9]. In the other known cases of laugh syncope
reported in the literature, more thorough and extensive
diagnostic evaluations were performed [3,5-8]. However,
all cases had a common characteristic history of transient
loss of consciousness following intense laughter, which
potentially could have obviated the need for an expensive
diagnostic evaluation. The burden of syncope evaluation
on the health care budget is significant. It has been esti-
mated that hospital admission of patients presenting with
Table 1: Classification of syncope
Cardiac
Aortic stenosis, hypertrophic cardiomyopathy, pulmonary embolism, aortic dissection, myocardial infarction, left atrial myxoma, cardiac tamponade, 
atrioventricular block, sick sinus syndrome, tachyarrhythmia, bradyarrhythmia
Neurally mediated (reflex mechanisms)
Vasovagal, situational (micturition, laughter, tussive, defecation, postprandial, sneeze, swallow), orthostatic syncope, carotid sinus syncope
Neurologic
Transient ischemic attack, subclavian steal syndrome, Takayasu disease, seizure
Metabolic
Hypoxia, hypoglycemia, hyperventilation
Psychiatric
Panic disorder, conversion reaction, hysteria
Drug-induced
Vasodilators (nitrates, calcium channel blockers, angiotensin-converting enzyme inhibitors), phenothiazines, antidepressants (tricyclic agents, 
monoamine oxidase inhibitors), central nervous system depressants (barbiturates), drugs associated with torsades de pointes (quinidine, 
procainamide, disopyramide, amiodarone, sotalol, flecainide), diuretics, digitalis, insulin, marijuana, alcohol, cocaine
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syncope for inpatient evaluation costs the health care sys-
tem more than US$2.4 billion dollars per year in the USA
[10].
To date, numerous causes of syncope have been recog-
nized (Table 1). This presents a diagnostic challenge to cli-
nicians. In the initial evaluation of syncope patients, the
diagnostic rate is estimated to be only 20% to 50% [1].
Even after extensive diagnostic work-up, no cause can be
identified in 15% to 30% of patients [1]. There is no diag-
nostic 'gold standard' for syncope. A careful history, phys-
ical examination and electrocardiogram (ECG) are usually
the most efficacious means used to establish a diagnosis
or determine the need for further diagnostic testing [11].
Unlike history and physical examination, ECG actually
has a low diagnostic yield [1]. It should be included in the
initial syncope evaluation, however, because it is nonin-
vasive, relatively inexpensive and can detect potentially
life-threatening conditions. Extensive laboratory and
imaging studies rarely provide useful diagnostic informa-
tion unless specifically indicated. Unfortunately, the eval-
uation of patients presenting with syncope is frequently
unable to reveal a clear etiology and many cases remain
unexplained.
With syncope patients, emergency physicians are often
confronted with the difficult decision of whether the
patient should be admitted for inpatient evaluation and
management. Syncope patients are frequently admitted
following an initial non-diagnostic evaluation because of
concerns of underlying life-threatening conditions (for
example, dysrhythmias, pulmonary embolism or acute
coronary syndrome) or belief that inpatient evaluation
will reveal the cause [12]. So the question of who should
be hospitalized for syncope remains. As noted previously,
the diagnostic yield of extensive work-up is relatively
poor. The focus in syncope evaluation, therefore, has
shifted from attempting to make a specific diagnosis to
risk stratification. Through careful risk stratification, it is
hoped that health care resources will be more efficiently
allocated to those patients most at risk of serious outcome
and, hence, more likely to benefit from inpatient care. In
a recent update of their 2001 clinical policy on syncope,
the American College of Emergency Physicians empha-
sized the use of history, physical examination and stand-
ard 12-lead ECG to risk-stratify patients and admit those
with risk factors for adverse outcome such as heart failure,
coronary artery disease, structural heart disease, older age,
concurrent comorbidities, hematocrit less than 30% (if
obtained) or abnormal ECG [1].
Several other studies have also developed clinical decision
rules to aid in the risk stratification of syncope patients.
The San Francisco Syncope Rule (SFSR) has been shown
to be sensitive in identifying patients at risk of serious out-
come within 7 days of initial emergency department pres-
entation based on the following predictors: abnormal
ECG, shortness of breath, systolic blood pressure under
90 mm Hg, hematocrit less than 30% and congestive heart
failure by history or examination [13]. However, another
external validation cohort found that the SFSR had a
lower sensitivity and specificity than reported previously
suggesting that the rule may require further validation
before it can be applied safely in clinical practice [14].
The prognosis for patients presenting with syncope varies
according to the underlying etiology. One population-
based study found that cardiac and neurologic syncope
were associated with an increased risk of death from any
cause and an increased risk of cardiovascular events and
stroke, respectively [15]. By comparison, patients with
vasovagal, orthostatic, medication-induced and situa-
tional syncope had no increase in the risk of death from
any cause compared with patients without syncope [15].
Although laugh syncope was not specifically addressed in
this study, as a type of situational syncope, we extrapolate
that its prognosis is likely benign. To the best of our
knowledge, no study to date has investigated the progno-
sis of laugh syncope.
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